Samuel Seidlin
Samuel M. Seidlin (1 May 1895 - 1955) was Russian-born American endocrinologist who pioneered the field of
radioiodine for diagnosis and therapy of thyroid cancer during the early 1940s.[1]
Early life
Samuel Seidlin was born in
Columbia University Vagelos College of Physicians and Surgeons and served as an intern and junior staff member at Johns Hopkins Hospital in Baltimore.[2][3]
Career
Seidlin established the Medical Physics Research Laboratory at Montefiore Hospital and its Endocrine Clinic in 1943.metastases from adenocarcinoma of the thyroid.[5] Seidlin continued as chief of the Endocrine Clinic and the Medical Physics Research Laboratory at Montefiore and treated 23 patients for metastatic thyroid cancer with radioiodine, utilizing from reactors for most of them.[3]
References
- ^ Surks 2012.
- ^ a b "Dr. Samuel M. Seidlin". geni.com. Retrieved 8 January 2019.
- ^ a b Seidlin, Marinelli & Oshry 1946.
- ^ "Samuel M. Seidlin". columbia.edu. Retrieved 6 January 2019.
- ^ a b Siegel 1999.
- ^ Hertz 1946.
Sources
- PMID 20251138.
- Seidlin, S M; Marinelli, L D; Oshry, E (1946). "RADIOACTIVE IODINE THERAPY – Effect on Functioning Metastases of Adenocarcinoma of the Thyroid". PMID 20274882.
- Siegel, E (1999). "The beginnings of radioiodine therapy of metastatic thyroid carcinoma: a memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient". Cancer Biotherapy & Radiopharmaceuticals. 14 (2): 71–79. PMID 10850290.
- Surks, Martin J (2012). "Milestones in Thyroid Research at Einstein and Montefiore: 1920-2011". Division of Endocrinology & Diabetes. Yeshiva U. Archived from the original on 16 September 2017.